COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,749 Articles (22,502 medRxiv, 8,247 bioRxiv)

Most recent first Previous |  Page 2207: Articles 22061-22070  | Next

Ventilation and the SARS-CoV-2 CoronavirusAnalysis of outbreaks in a restaurant and on a bus in China,and at a Call Center in South Korea
Birnir, B.
10.1101/2020.09.11.20192997 — Posted: 2020-09-13 Discussion: Onsite
Impact and Correlation of Air Quality and Climate Variables with COVID-19 Morbidity and Mortality in Dhaka, Bangladesh
Salam, A.
10.1101/2020.09.12.20193086 — Posted: 2020-09-13 Discussion: Offsite
Automatic Contact Tracing for Outbreak Detection UsingHospital Electronic Medical Record Data
DeWitt, M. E.
10.1101/2020.09.08.20190876 — Posted: 2020-09-13
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Chen, X., Chen, Z., Azman, A. S., Deng, X., Chen, X., Lu, W., Zhao, Z., Yang, J., Viboud, C., Ajelli, M., Leung, D. T., Yu, H.
10.1101/2020.09.11.20192773 — Posted: 2020-09-13
Mask-Wearing During the COVID-19 Pandemic
Aravindakshan, A., Boehnke, J., Gholami, E., Nayak, A.
10.1101/2020.09.11.20192971 — Posted: 2020-09-13
On Machine Learning-Based Short-Term Adjustment of Epidemiological Projections of COVID-19 in US
KEFAYATI, S., Huang, H., Chakraborty, P., Roberts, F., Gopalakrishnan, V., Srinivasan, R., Pethe, S., Madan, P., Deshpande, A., Liu, X., Hu, J., Jackson, G.
10.1101/2020.09.11.20180521 — Posted: 2020-09-13
The Effect of Early Hydroxychloroquine-based Therapy in COVID-19 Patients in Ambulatory Care Settings: A Nationwide Prospective Cohort Study
Sulaiman, T., Mohana, A., Alawdah, L., Mahmoud, N., Hassanein, M., Wani, T., Alfaifi, A., Alenazi, E., Radwan, N., AlKhalifah, N., Elkady, E., AlAnazi, M., Alqahtani, M., Abdalla, K., Yousif, Y., AboGazalah, F., Awwad, F., AlabdulKareem, K., AlGhofaili, F., AlJedai, A., Jokhdar, H., Alrabiah, F.
10.1101/2020.09.09.20184143 — Posted: 2020-09-13 Discussion: Onsite
Development of a serological assay to identify SARS-CoV-2 antibodies in COVID-19 patients
Huynh, A., Arnold, D. M., Kelton, J. G., Smith, J. W., Moore, J. C., Chetty, V. T., Stacey, H. D., Ang, J. C., Chagla, Z., Harvey, B. J., Bowdish, D. M., Miller, M. S., Nazy, I.
10.1101/2020.09.11.20192690 — Posted: 2020-09-13
Shedding of infectious SARS-CoV-2 from airways in hospitalized COVID-19 patients in relation to serum antibody responses
Glans, H., Gredmark-Russ, S., Olausson, M., Falck-Jones, S., Varnaite, R., Christ, W., Maleki, K. T., Lind Karlberg, M., Broddesson, S., Falck-Jones, R., Bell, M., Johansson, N., Farnert, A., Smed Sorensen, A., Klingstrom, J., Brave, A.
10.1101/2020.09.11.20191940 — Posted: 2020-09-13
RAAS blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis
Kaur, U., Chakrabarti, S. S., Patel, T. K.
10.1101/2020.09.09.20191445 — Posted: 2020-09-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).